Skip to content
OMNIBOT MX

Feasibility · Telesurgery / urology · 2025

Safety and reliability of telesurgery in China: a multicenter, single-arm, phase I clinical trial

This is early human feasibility evidence under a specific protocol. Network quality and bedside backup are part of that context, not transferable guarantees. A hospital considering remote surgery needs its own technical validation, clinical safeguards and regulatory approvals.

For professional education and institutional evaluation. Published research is not authorization for use in Mexico or another country. Confirm the exact device, local registration, current instructions and institutional permissions before clinical use.

Publication metadata

Original publication authors
Sheng Tai; Ye Wang; Sunyi Ye; Tao Xu; Gen Cheng; Cheng Yang; Hongzhi Wang; Haibing Xiao; Qingbo Huang; Shuo Wang; Xiangping Zhang; Jianle Mao; Nan Qiao; Zongyao Hao; Dan Xia; Wanhai Xu; Xu Zhang; Chaozhao Liang
Journal / year
International Journal of Surgery; 111(10):6678–6687 · 2025
Robot model
EDGE MP1000
Verification scope
Full text and bibliographic metadata

Independent analysis

This is early human feasibility evidence under a specific protocol. Network quality and bedside backup are part of that context, not transferable guarantees. A hospital considering remote surgery needs its own technical validation, clinical safeguards and regulatory approvals.

Study sample

18 patients across four hospitals; single-arm phase I trial.

Measured outcomes

Telesurgery was reported successful in 18/18 patients within this study. Distances 450–2200 km; mean round-trip network latency 38.38 ± 13.25 ms; no frame loss reported. These network measurements describe the study environment only.

Limitations

Small uncontrolled cohort and supported network conditions; selection and surgeon experience limit generalizability. No authorization for routine or cross-border use follows.

Source-based editorial analysis by OMNIBOT MX. No independent medical reviewer is asserted. Read the original publication and assess applicability with your institution. Publication year refers to the original research, not a fabricated date for this analysis. No medical review or review date is claimed. Published device names are preserved; commercial equivalence with OMNIBOT requires manufacturer documentation.

Reference

  1. Sheng Tai et al. Safety and reliability of telesurgery in China: a multicenter, single-arm, phase I clinical trial International Journal of Surgery; 111(10):6678–6687. 2025. DOI: 10.1097/JS9.0000000000002792. Open original source

Related analyses

Request evidence documentation